TriSalus Life Sciences, Inc.

Ownership Transactions Reported by 22 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	5	+178K	85.5%	$4.73	+$843K
Sells	3	-30.3K	14.5%	$3.70	-$112K
Net	+2	+148K	70.9%		+$731K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
MedTech Acquisition Sponsor LLC	10%+ Owner	$65.5M			Jun 26, 2023
Frankenius Equity AB	10%+ Owner	$24.7M	+$250K	+1.02%	Feb 10, 2025
Mats Wahlstrom	Director, 10%+ Owner	$10.6M	+$69.8K	+0.66%	Feb 10, 2025
David J. Matlin	Director	$5.63M			Feb 10, 2025
Sean Murphy	Chief Manuf, Strategy&Bus Dev., Director	$3.58M	+$157K	+4.59%	Feb 18, 2025
Mary T. Szela	CEO AND PRESIDENT, Director	$2.63M	+$202K	+8.33%	Feb 18, 2025
George Kelly Martin	Director	$1.36M	-$50	0%	Aug 28, 2024
Arjun JJ Desai	Director	$912K	-$111K	-10.8%	Dec 10, 2024
Bryan F. Cox	Chief Of Research	$613K	-$1.39K	-0.23%	Feb 18, 2025
James Alecxih	President, Device Technology	$521K			Aug 10, 2023
Steven C. Katz	Chief Medical Officer	$377K			Feb 12, 2024
James Emmett Young	Chief Financial Officer	$376K	+$164K	+77.1%	Feb 18, 2025
Jennifer Stevens	Chief Regulatory Officer	$327K			Feb 18, 2025
Richard Marshak	Chief Commercial Officer	$307K			Feb 18, 2025
Jodi Devlin	Chief of Clinical Operations	$189K			Feb 18, 2025
Magnetar Financial LLC	10%+ Owner	$175K			Jun 12, 2023
Liselotte Hyveled	Director	$39.9K			Jan 2, 2025
William Valle	Director				Jan 29, 2025
Anil K. Singhal	Director				Aug 13, 2024
Gary B. Gordon	Director				Jan 29, 2025
Andrew Von Eschenbach	Director				Aug 13, 2024
R. Kerry Hicks	Director				Aug 13, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.